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1 The N-substituent of IQB-9302 has the same number of carbons as bupivacaine, but it exhibits a
dierent spatial localization (n-butyl vs cyclopropylmethyl). Thus, the study of the eects of IQB-
9302 enantiomers on hKv1.5 channels will lead to a better knowledge of the determinants of
stereoselective block.
2 The eects of the IQB-9302 enantiomers were studied on hKv1.5 channels stably expressed in
Ltk7 cells using the whole-cell configuration of the patch-clamp technique. Drug molecular
modelling was performed using Hyperchem software.
3 Block induced by IQB-9302 was stereoselective with the R(+) enantiomer being 3.2-fold more
potent than the S(7) one (KD of 17.8+0.5 mM vs 58.6+4.0 mM).
4 S(7)- and R(+)IQB-9302 induced-block was time- and voltage-dependent consistent with an
electrical distance from the cytoplasmic side of 0.173+0.022 (n=12) and 0.181+0.018 (n=10),
respectively.
5 Potency of block of pipecoloxylidide local anaesthetics was linearly related to the length between
the cationic tertiary amine and the end of the substituent.
6 Molecular modelling shows that only when S(7) and R(+) enantiomers are superimposed by
their aromatic ring, their N-substituents are in opposite directions, which can explain the
stereospecific block induced by bupivacaine and IQB-9302 with hKv1.5 channels.
7 These results suggest that: (a) IQB-9302 enantiomers block the open state of hKv1.5 channels,
and (b) the length of the N-substituent in these local anaesthetics and not its volume determines the
potency and degree of their stereoselective hKv1.5 channel block.
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Introduction
Local anaesthetics block the generation and conduction of
nerve impulses by inhibiting the current through voltage-
gated Na+ channels in the nerve cell membrane (Hille, 1977;
Hondeghem & Katzung, 1977; Strichartz, 1987). However,
voltage-gated Na+ channels from other tissues when exposed
to sucient concentrations of these agents will be blocked.
This can explain why the accidental intravascular injection or
the use of high concentrations of local anaesthetics can
produce profound systemic eects, especially in the central
nervous and cardiovascular systems (Strichartz, 1987).
Indeed, several local anaesthetics also exhibit class I
antiarrhythmic actions on the myocardium at concentrations
lower than those used for local anaesthesia (Hondeghem &
Katzung, 1977; Strichartz, 1987).
Bupivacaine is a potent local anaesthetic widely used for
long-lasting regional local anaesthesia (Strichartz, 1987).
Bupivacaine decreases intracardiac conduction velocity,
contractile force, depresses spontaneous sinoatrial activity
(Strichartz, 1987) and prolongs QRS and QTc intervals of the
ECG in anaesthetized dogs (Kasten & Martin, 1985; Wheeler
et al., 1988) and human volunteers (Scott et al., 1989)
receiving high doses of bupivacaine. It has been reported that
this cardiotoxicity is mostly related to the R(+) enantiomer
(A˚berg, 1972; Luduena et al., 1972) likely due to its higher
potency for blocking cardiac sodium and potassium channels
(Valenzuela et al., 1995a,b). In human cardiac myocytes, K+
currents activated by depolarization have been identified as
transient outward (ITO) (Escande et al., 1987; Shibata et al.,
1989; Beuckelmann et al., 1993; Wettwer et al., 1993) and
delayed rectifier currents, IKs, IKr and IKur (Fedida et al.,
1993; Wang et al., 1993a,b). The functional and pharmaco-
logic characteristics of IKur are similar to those reported for
the cloned cardiac human Kv1.5 channel, thus suggesting
that it is the native counterpart of hKv1.5 channels cloned
from human ventricle (Snyders et al., 1992; 1993; Fedida et
al., 1993; Wang et al., 1993a). Bupivacaine blocks several
potassium channels, including hKv1.5, Kv2.1, Kv4.3,
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KvLQT1+minK and HERG channels, the KD values being
*9, 22, 24, 200 and 17 mM, respectively (Lipka et al., 1998;
Franqueza et al., 1999; Gonza´lez et al., 2000a). However,
stereoselective bupivacaine block has only been demonstrated
on hKv1.5 channels, but not on Kv2.1 or Kv4.3 (Franqueza
et al., 1997; 1999).
IQB-9302 is a new amide type local anaesthetic, chemically
related to bupivacaine (Figure 1) (Gallego-Sandı´n et al.,
1999). Like bupivacaine, IQB-9302 blocks Kv2.1, Kv4.3 and
HERG channels with similar potency than bupivacaine (KD
*20 mM). IQB-9302 also inhibits hKv1.5 current, but it is 2.5
fold less potent than bupivacaine (KD=22 mM) (Gonza´lez et
al., 2000a). It contains a chiral carbon in its structure and
therefore, it can be separated into two enantiomers: R(+)
and S(7)IQB-9302. In this study we have analysed the eects
of both enantiomers on hKv1.5 channels. It will permit us to
better understand the structural determinants of pipecolox-
ylidide local anaesthetics induced-block of these channels,
since the N-substituent of IQB-9302 has the same number of
carbons than bupivacaine, but exhibits a dierent spatial
localization (n-butyl vs cyclopropylmethyl). Moreover, the
comparison of the results derived from this study with the
eects on hKv1.5 channels of bupivacaine and ropivacaine
enantiomers (Valenzuela et al., 1995a; 1997) will permit us to
hypothesize about the possible cardiotoxicity of this new
local anaesthetic. Preliminary results of this study have been
published in abstract form (Gonza´lez et al., 1999; 2000b).
Methods
Electrophysiological recording
Use of the stable Ltk7 cell line expressing hKv1.5 channels
has been described previously in detail (Valenzuela et al.,
1995a; Franqueza et al., 1997; Longbardo et al., 1998). The
intracellular pipette filling solution contained (in mM): K-
aspartate 80, KCl 50, phosphocreatine 3, KH2PO4 10,
MgATP 3, HEPES-K 10, EGTA 5 and was adjusted to pH
7.25 with KOH. The bath solution contained (in mM): NaCl
130, KCl 4, CaCl2 1.8, MgCl2 1, HEPES-Na 10, and glucose
10, and was adjusted to pH 7.40 with NaOH.
hKv1.5 currents were recorded at room temperature (20 –
228C) using the whole-cell patch-clamp technique (Hamill et
al., 1981) with an Axopatch 1C patch-clamp amplifier (Axon
Instruments, Foster City, CA, U.S.A.). Currents were filtered
at 2 kHz (four-pole Bessel filter) and sampled at 4 kHz.
Micropipettes were pulled from borosilicate glass capillary
tubes (Narishige, GD-1, Tokyo, Japan) on a programmable
horizontal puller (Sutter Instrument Co., San Rafael, CA,
U.S.A.) and heat-polished with a microforge (Narishige).
Micropipettes resistance were 1 – 3 MO. Capacitance and
series resistance compensation were optimized, and 80%




tiomers (gift from Dr A. Galiano, IQB-Inibsa S.A., Spain)
were dissolved in distilled deionized water to yield stock
solutions of 10 mM from which further dilutions were made
to obtain the desired final concentration in each experi-
ment.
Pulse protocol and analysis
Cells were held at 780 mV. After control data were
obtained, bath perfusion was switched to drug-containing
solution. The eects of drug infusion was monitored with
test pulses to +60 mV, applied every 10 s until steady-state
was obtained (after *12 min). Steady-state current-voltage
relationships (IV) were obtained by averaging the current
over a small window (2 – 5 ms) at the end of 250 ms
depolarizing pulses. Between 780 and 740 mV only
passive linear leak was observed and least squares fits to
these data were used for passive leak correction. Deactivat-
ing ‘tail’ currents were recorded at 740 mV. The activation
curve was obtained from the tail current amplitude
measured just after the capacitive transient. Command
potentials, data acquisition and measurements were done
using PCLAMP 6.0.1., Origin 5.0 (Microcal Software,
Northampton, MA, U.S.A.) and by a custom-made analysis
program.
Apparent anity constants, KD, and Hill coecients, nH,
were obtained from fitting of the fractional block, f, at
various drug concentrations [D]:
f  1=1 KD=Dn H 1
and apparent rate constants for binding (k) and unbinding (l)
were obtained from:
k D  l  1=tB  l 2a
l=k  KD 2b
where tB represents the time constant of the drug-induced
fast initial decline during depolarization to +60 mV.
The dominant time constant of the activation process was
analysed fitting it to a single exponential, following a
procedure previously described and used for the same
purpose (Valenzuela et al., 1995a). Deactivation and
inactivation were fitted to a biexponential process:
y  CA1expÿt=t1 A2expÿt=t2  . . .Anexpÿt=tn
3
where t1, t2 ... tn are the system time constants, A1, A2 ... An
are the amplitudes of each component of the exponential, and
C is the baseline value. Half-maximal voltages (Eh) and slope
factors (s) of activation were determined by fitting data with
a Boltzmann equation: y  1=1 expÿEÿ Eh=s. The
Figure 1 Chemical structure of bupivacaine and IQB-9302. The
asterisk indicates the asymmetric carbon in the molecule.
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curve-fitting procedure used a non-linear least-squares
(Gauss-Newton) algorithm; results were displayed in linear
and semilogarithmic format, together with the dierence plot.
Goodness of fit was judged by the w2 criterion and by
inspection for systematic non-random trends in the dierence
plot.
Voltage dependence of block was determined as follows:
leak-corrected current in the presence of drug was normalized
to matching control to yield the fractional block at each
voltage (f=17Idrug/Icontrol). The voltage dependence of block
was fitted to:
f  D=D  KD   expÿdzFE=RT; 4
where z, F, R and T have their usual meaning, d represents
the fractional electrical distance, i.e., the fraction of the
transmembrane electrical field sensed by a single charge at the
receptor site and KD* represents the apparent dissociation
constant at the reference potential (0 mV).
Molecular modelling
Models of bupivacaine analogues with dierent N-substitu-
ents (n-butyl, cyclopropylmethyl, n-propyl and methyl) in
their cationic forms were constructed and energy minimized
with the Hyperchem software 5.1 (Molecular modelling
system. Hypercube, Inc. and Autodesk Inc., 1998) following
procedures previously reported (Lo´pez-Belmonte et al., 1997).
MM+ force field and the conjugated algorithm Fletcher-
Reeves were used to minimize the structures. MNDO
semiempirical method was used to calculate the charges and
molecular orbitals.
Statistical methods
Results are expressed as mean+s.e.mean. Comparisons
between mean values in control conditions and in the
presence of drug for a single variable were performed by
paired Student’s t-test. Dierences were considered significant
if P50.05.
Results
Figure 2 shows original hKv1.5 current records obtained in
control conditions, in the presence of 50 mM S(7)IQB-9302
or R(+)IQB-9302, and after washout with drug-free external
solution. Under control conditions, hKv1.5 current activates
rapidly, reaches a maximum peak current and slowly
inactivates, as previously described (Valenzuela et al.,
1995a). At 50 mM, both enantiomers inhibited hKv1.5
current, being R(+)IQB-9302 3.2 fold more potent than
S(7)IQB-9302, (70.4+3.0%, n=4, vs 46.5+3.1%, measured
at +60 mV, n=10, P50.01, respectively). The eects of both
enantiomers were reversible upon perfusion of the cells with
drug-free external solution (93+1% of the control values,
n=23). S(7)IQB-9302 or R(+)IQB-9302 did not modify the
activation kinetics of the current (1.28+0.11 ms vs
1.06+0.11 ms, n=8, P40.05; and 1.73+0.20 ms vs
1.27+0.04, n=6, P40.05; respectively), but induced a fast
decline of the current at the beginning of the depolarizing
pulse, faster at higher drug concentrations, suggesting an
open channel block mechanism.
Figure 3 shows the concentration response curve when
using as an index of block the suppression of the current
induced by both enantiomers at the end of 250 ms
depolarizing pulses to +60 mV. A non-linear least-squares
fit of the concentration-response equation yielded, for
S(7)IQB-9302, a KD and the nH values of 58.6+4.0 mM
and 0.874+0.055, respectively. For R(+)IQB-9302, these
values averaged 17.8+0.5 mM and 0.912+0.025. When nH
was fixed to unity, the KD values for S(7)IQB-9302 and
R(+)IQB-9302 were 58.1+5.1 mM (P40.05) and
18.1+0.9 mM (P40.05).
Voltage dependence of IQB-9302 induced block of hKv1.5
channels
Figure 4A shows the IV relationships obtained in the absence
and in the presence of either S(7)IQB-9302 (50 mM) or
R(+)IQB-9302 (10 mM). Both enantiomers decreased the
amplitude of the current at membrane potentials positive to
710 mV, although the inhibition of the current was more
pronounced at more positive than at more negative
membrane potentials, thus suggesting an open channel block
mechanism similar to that described for bupivacaine,
ropivacaine and mepivacaine enantiomers (Valenzuela et al.,
1995a; 1997; Longobardo et al., 1998). In order to quantitate
this voltage dependence we represented the relative current in
the presence of either 50 mM S(7)IQB-9302 or 10 mM
R(+)IQB-9302 vs membrane potential (Figure 4B). Block
steeply increased in the range of membrane potentials of the
activation of the channels, which indicates that the drug
needs the channel to open before it can bind. At membrane
potentials positive to 0 mV a shallower but significant
increase in block was observed. Both enantiomers are weak
bases (pKa=7.99+0.006) and thus, they are predominantly
charged at the physiological pH. Therefore, this increase in
block can be attributed to the eect of the transmembrane
electrical field on the interaction between the cationic drug
and the channel. Following a Woodhull formalism (Wood-
hull, 1973), a non linear curve fitting of the data yielded
apparent dissociation constant at the reference potential
(0 mV) (KD*) and the fractional electrical distance from the
inner side of the membrane (d). In the presence of S(7)IQB-
9302 and R(+)IQB-9302 the d values averaged 0.173+0.022
(n=12) and 0.181+0.018 (n=10), respectively, indicating
that they have to cross *18% of the transmembrane
electrical field to bind their receptor site in the hKv1.5
channel. In addition, the calculated KD* averaged
78.8+26.3 mM (n=9) and 29.7+2.2 mM (n=10) for
S(7)IQB-9302 and R(+)IQB-9302, respectively.
Time-dependent block
S(7) and R(+)IQB-9302 induced a fast initial decline of the
current which was superimposed to the slow inactivation at
concentrations higher than 100 and 10 mM, respectively
(Figure 5A). The time constant of this decline of the current
was lower at higher drug concentrations and thus, it was
considered to be a good index of the kinetics of binding of
the drug (tB). From the tB values, the apparent drug
association (k) and dissociation (l) constants were calculated.
For S(7)IQB-9302, k and l were 0.60+0.08 mM71 s71 and
39.7+5.2 s71 (n=13), respectively. For R(+)IQB-9302, k
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was 4.6 fold higher than that obtained for S(7)IQB-9302
(2.90+0.63 mM71 s71, n=7, P50.01) whereas l remained
similar to S(7)IQB-9302 (52.2+11.4 s71, n=7, P40.05).
Figure 5B shows superimposed current traces obtained on
return to 740 mV under control conditions and in the
presence of S(7)IQB-9302 (20 mM) or R(+)IQB-9302
(10 mM). Under control conditions, the deactivating process
was fitted following a biexponential process with a fast (tf)
and a slow (ts) time constants. S(7)IQB-9302 increased the
two time constants from 17.9+3.3 and 58.6+12.3 ms to
31.2+4.0 ms (n=5, P50.05) and 167.4+30.4 ms (n=5,
P50.05). R(+)IQB-9302 increased the two process of
deactivation from 18.7+2.9 and 48.4+6.5 ms to
28.0+5.0 ms (n=5, P50.05) and 73.0+8.6 ms (n=5,
P50.05). Upon repolarization, channel deactivation is fast
and virtually irreversible. If a large fraction of channels are
blocked (OD) and the unbinding rate (l) is fast enough, then
the tail current may display a rising phase reflecting the
dissociation of the drug from the blocked open channels
(OD?O). Subsequently, channels reach the open state and
may be blocked again before they deactivate. This process
will be reflected by a slower time course of the tail current
and, thus, a tail ‘crossover’ suggestive of open channel block
will be observed (Armstrong, 1971).
Discussion
IQB-9302 enantiomers block the open state of hKv1.5
channels
There are several pieces of evidence suggesting that IQB-9302
enantiomers block hKv1.5 channels by binding to the open
state. First, at high concentrations, both enantiomers induced
a fast initial decline of the maximal activated current, that
superimposes to the intrinsic C-type inactivation of these
channels. Second, block steeply increased in the range of
activation of the hKv1.5 channels activation, indicating that
the drug needs the channel to open to bind to its receptor site
and block the K+ eux. Finally, when the tail currents
obtained in the absence and in the presence of each
enantiomer were superimposed, we observed a tail current
‘crossover’, indicating fast recovery from block during
deactivation, consistent with an open channel block mechan-
ism (Armstrong, 1971; Valenzuela et al., 1995a).
Figure 2 Eects of IQB-9302 enantiomers on hKv1.5 currents. Currents are shown for depolarization from 780 mV to voltages
between 780 and +60 mV in steps of 10 mV. Tail currents were obtained on return to 740 mV. Traces were obtained in the
absence (left panel), in the presence of 50 mM of each enantiomer of IQB-9302 (middle panel) and after washout with drug-free
external solution (right panel). All records shown in this Figure were recorded from the same cell, which was first perfused with
S(7)IQB-9302 and afterwards with R(+)IQB-9302. The control for R(+)IQB-9302 is the washout of S(7)IQB-9302. Cell
capacitance, 23 pF.
Figure 3 Concentration dependence of IQB-9302 enantiomers-
induced block of hKv1.5 channels. Reduction of current (relative
to control) at the end of depolarizing steps from 780 mV to
+60 mV was used as index of block. Data are mean+s.e.mean of a
total of 51 experiments. The continuous line represents the fit of the
experimental data to the equation: 1=1 KD=Dn H.
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Affinity related to the length between the tertiary amine
and the end of the N-substituent
Bupivacaine, ropivacaine, IQB-9302 and mepivacaine only
dier in the N-substituent which is a n-butyl, n-propyl,
cyclopropylmethyl and methyl, respectively. In order to
quantitate the relationship between the anity and the
structure of these compounds (as cations), logKD was plotted
against several molecular parameters as logP, van der Waals
volume, atomic charges or energy of HOMO or LUMO, but
no significant interactions were obtained. Nevertheless, the
relationship between the anity constant and the length of
the alkyl chain bond to the tertiary nitrogen (in A˚) revealed a
good correlation coecient (Figure 6) (Valenzuela et al.,
1995a; 1997; Longobardo et al., 1998). For each pair of
enantiomers, we could observe a good linear relationship
between the potency and the length of the N-substituent
group, suggesting that this region of the molecule determines
the potency of the drug.
Stereoselective block of hKv1.5 channels induced by
IQB-9302
Block induced by IQB-9302 was stereoselective. As observed
with bupivacaine (Valenzuela et al., 1995a), the more potent
enantiomer was the R(+) one, although for IQB-9302, the
degree of stereoselective block was lower than that observed
for bupivacaine. The dierence in potency between both
enantiomers was related to a faster association rate constant,
like it occurs with bupivacaine and ropivacaine (Valenzuela et
al., 1995a; 1997; Longobardo et al., 1998). Stereoselective
interactions suggest that unidirectional structural properties
of the chain such as hydrophobicity (logP) or van der Waals
volume (Vw) cannot be the factor responsible for dierences
in potency (Figure 6). In contrast, it seems to be the
consequence of some stereochemical property of the drug,
such as the length of the N-substituent, which would adopt
opposite spatial localization for each pair of enantiomers.
To further analyse this issue, the minimum energy
conformers of the N-protonated bupivacaine (N-n-butyl),
ropivacaine (N-n-propyl), IQB-9302 (N-cyclopropylmethyl)
and mepivacaine (N-methyl) were modelled using the
Hyperchem program. The cationic forms were selected
because all these drugs are weak bases (with pKa values
*8) and, therefore, they will be mostly protonated at the
physiological pH. This analysis was carried out both for
S(7) and R(+) enantiomers and docking of the conformers
of minimum energies were performed in order to explore
sterical dierences. Figure 7A,B show the minimum energy
conformers of the two enantiomers of bupivacaine and IQB-
9302 superimposed by the piperidine ring. Under these
circumstances, each pair of enantiomers fit almost comple-
Figure 4 Voltage dependence of hKv1.5 block by IQB-9302 enantiomers. (A) Current-voltage relationship (250 ms isochronal) in
control conditions and in the presence of 50 mM S(7)IQB-9302. (B) Relative current expressed as IS(7)IQB-9302/IControl from data
shown in (A). (C) Current-voltage relationship (250 ms isochronal) in control conditions and in the presence of 10 mM R(+)IQB-
9302. (D) Relative current expressed as IR(+)IQB-9302/IControl from data shown in (C). The dashed lines in (B) and (D) represent the
activation curve of the hKv1.5 channel for each experiment. In both cases, block increased steeply between 720 and 0 mV, which
corresponds to the voltage range of activation of hKv1.5. For membrane potentials positive to 0 mV, a continued but more shallow
voltage dependence was observed. This voltage dependence was fitted (continuous line) with eq. 4 (see Methods) and yielded
d*0.18.
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tely, which does not explain the experimental results that
revealed the 7- and 3.2 fold dierences in potency for
bupivacaine and IQB-9302, respectively (Valenzuela et al.,
1995a). Figure 7C,D show the superimposed S(7) and R(+)
enantiomers of bupivacaine and IQB-9302, in this case by
their aromatic rings. It is observed that in both cases S(7)
and R(+) enantiomers dier in the position of the N-
substituents, which are in opposite directions for each
enantiomer. According to Figure 6, R(+) enantiomers adopt
a more favourable conformation in energetic terms than the
S(7) enantiomers, that explain their higher potency. This
simple approach led us to postulate a simple recognition
model for this type of local anaesthetics (Valenzuela et al.,
1995a; 1997; Longobardo et al., 1998), suggesting a restrictive
site for the recognition of the aromatic ring. Under this
hypothesis, first, the aromatic ring of the drug would interact
with an amino acid containing an aromatic ring (Phe, Tyr or
Trp) establishing a p – p interaction between both aromatic
rings, which are more stable, in energetic terms, than the
hydrophobic interaction between alkyl chains. Therefore,
they have been described as crucial for this kind of
compound when they interact with other proteins such as
pancreatic porcine lipase (Borreguero et al., 1999). After-
wards, the N-substituent would interact with some of the two
Figure 5 Time-dependent block induced by IQB-9302 enantiomers. (A) Superimposed traces for steps from 780 mV to +60 mV
under control conditions and in the presence of 500 mM S(7)IQB-9302 and 50 mM R(+)IQB-9302. (B) Tail current crossover.
Currents recorded in control conditions and in the presence of 20 mM S(7)IQB-9302 or 10 mM R(+)IQB-9302 were superimposed.
Tail currents were obtained at 740 mV after a 250 ms-depolarizing pulse to +60 mV. Arrow shows the crossover of tracings
recorded in the presence of IQB-9302 enantiomers with those recorded under control conditions.
Figure 6 Relationship between the potency of block of hKv1.5 channels and the maximal length between the tertiary amine and
the end of the N-substituent in mepivacaine, IQB-9302, ropivacaine and bupivacaine.
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amino acids previously identified as part of the receptor site
for bupivacaine in hKv1.5 channels: Leu or Val at positions
508 and 512, respectively (Franqueza et al., 1997). Under this
approach, this interaction is stereocontrolled by the stereo-
chemistry of the chiral carbon of the local anaesthetic, as we
can observe in Figure 7C,D. Possible candidates for the
anchoring of the aromatic ring of the pipecoloxylidide type
local anaesthetics in hKv1.5 channels would be F437 and
F438, located at the S5 segment, although we cannot exclude
other aromatic amino acids present at the inner part of the
ion pore region. Indeed, following the recent proposed
structural ‘bent S6’ model for Kv channels by Del Camino
et al. (2000), some of the aromatic amino acids of the
F(N)YFY amino acid sequence at the inner part of the ion
pore would be responsible for the anchoring of this kind of
drug in hKv1.5 channels. However, a more detailed
Molecular Dynamic study is needed to verify this theoretical
hypothesis.
Conclusions
The results obtained in the present study show that both
potency of block of hKv1.5 channels and the degree of
stereoselective block is lower in the presence of IQB-9302
than in the presence of bupivacaine (Valenzuela et al., 1995a),
which could be related to lesser cardiotoxic eects than those
previously reported for bupivacaine. Therefore, IQB-9302
could represent a less cardiotoxic alternative to bupivacaine.
Moreover, the molecular modelling of these results suggest
that potency and stereoselective hKv1.5 block induced by
bupivacaine-like local anaesthetics are related to the length of
their N-substituent and not to its hydrophobicity or van der
Waals volume. As a qualitative binding model, we propose
that these drugs may first bind to the hKv1.5 channels by
anchoring the aromatic ring onto some aromatic amino acid
and this interaction could redirect the entire molecule
determining the spatial localization of the N-substituent, that
will interact with L508 and/or V512 at the S6 level
(Franqueza et al., 1997).
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